Clinuvel Pharmaceuticals Limited (CLVLY)
OTCMKTS · Delayed Price · Currency is USD
7.30
+0.25 (3.51%)
Sep 5, 2025, 12:11 PM EDT
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of $371.02 million as of September 5, 2025. Its market cap has decreased by -19.00% in one year.
Market Cap
371.02M
Enterprise Value
224.30M
Revenue
62.29M
Ranking
n/a
PE Ratio
15.64
Stock Price
$7.30
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 2.79M to 371.02M, an increase of 13,203.21%. That is a compound annual growth rate of 22.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 371.02M | -0.47% |
| Dec 31, 2024 | 372.77M | -31.82% |
| Dec 29, 2023 | 546.72M | -24.87% |
| Dec 30, 2022 | 727.74M | -25.56% |
| Dec 31, 2021 | 977.57M | 14.90% |
| Dec 31, 2020 | 850.82M | -13.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 891.61M |
| Elite Pharmaceuticals | 751.15M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 631.79M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 394.86M |
| American Oncology Network | 353.52M |